MapLight Therapeutics, Inc. (MPLT)

NASDAQ: MPLT · Real-Time Price · USD

11.98

-0.20 (-1.64%)

At close: Aug 11, 2026, 4:00 PM EDT

12.00

+0.02 (0.17%)

After-hours: Aug 11, 2026, 7:54 PM EDT

MapLight Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-210.04	-169.08	-82.95
Net Income	-199.48	-161.15	-77.58
Earnings Per Share	-80.12	-18.56	-105.38
EPS Growth	-	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	310.11	305.1	108.8
Total Debt	5.59	5.8	6.58
Net Cash (Debt)	304.52	299.3	102.22
Net Cash Growth	197.92%	192.81%	-
Net Cash Per Share	15.42	34.48	138.85

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-163.77	-138.14	-78.82
Capital Expenditures	-0.5	-0.47	-0.77
Free Cash Flow	-164.26	-138.61	-79.59
Free Cash Flow Growth	-	-	-

Selected indicators aren't available for this stock.